Trial Profile
Biomime Biosorbable Polymer Sirolimus-ELuting Stent in alL-comers patIeNts Treated With Percutaneous Coronary Interventions: the BELLINI Registry
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Mar 2017
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- Acronyms BELLINI
- 31 Mar 2015 New trial record